P.A. Elkins

1.6k total citations
10 papers, 862 citations indexed

About

P.A. Elkins is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, P.A. Elkins has authored 10 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Genetics. Recurrent topics in P.A. Elkins's work include Bacterial Genetics and Biotechnology (3 papers), Cancer-related gene regulation (2 papers) and RNA and protein synthesis mechanisms (2 papers). P.A. Elkins is often cited by papers focused on Bacterial Genetics and Biotechnology (3 papers), Cancer-related gene regulation (2 papers) and RNA and protein synthesis mechanisms (2 papers). P.A. Elkins collaborates with scholars based in United States and United Kingdom. P.A. Elkins's co-authors include Cynthia V. Stauffacher, William Cramer, Amy Bunker, Fred Cohen, William A. Cramer, Sharon L. Schendel, Cheryl A. Janson, Ward W. Smith, Michael S. McQueney and Karla D'Alessio and has published in prestigious journals such as Journal of Molecular Biology, Journal of Medicinal Chemistry and Proteins Structure Function and Bioinformatics.

In The Last Decade

P.A. Elkins

10 papers receiving 844 citations

Peers

P.A. Elkins
Natalia Matassova United Kingdom
Thorsten Nowak United Kingdom
M.G. Grütter Switzerland
Pete Dunten United States
Bruce A. Beutel United States
Kesavan Radika United States
Ewa S. Pilka United Kingdom
Andrew Pannifer United Kingdom
Werner Klaus Switzerland
Natalia Matassova United Kingdom
P.A. Elkins
Citations per year, relative to P.A. Elkins P.A. Elkins (= 1×) peers Natalia Matassova

Countries citing papers authored by P.A. Elkins

Since Specialization
Citations

This map shows the geographic impact of P.A. Elkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.A. Elkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.A. Elkins more than expected).

Fields of papers citing papers by P.A. Elkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.A. Elkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.A. Elkins. The network helps show where P.A. Elkins may publish in the future.

Co-authorship network of co-authors of P.A. Elkins

This figure shows the co-authorship network connecting the top 25 collaborators of P.A. Elkins. A scholar is included among the top collaborators of P.A. Elkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.A. Elkins. P.A. Elkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Aller, Glenn S. Van, Alan P. Graves, P.A. Elkins, et al.. (2016). Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets. Structure. 24(5). 774–781. 42 indexed citations
2.
Carlson, Heather A., Richard D. Smith, Kelly L. Damm‐Ganamet, et al.. (2016). CSAR 2014: A Benchmark Exercise Using Unpublished Data from Pharma. Journal of Chemical Information and Modeling. 56(6). 1063–1077. 82 indexed citations
3.
Lin, Hong, Dennis S. Yamashita, Jin Zeng, et al.. (2009). 2,3,5-Trisubstituted pyridines as selective AKT inhibitors—Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity. Bioorganic & Medicinal Chemistry Letters. 20(2). 673–678. 11 indexed citations
4.
Sehon, Clark A., Andrew Q. Viet, Krista Goodman, et al.. (2008). Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases. Journal of Medicinal Chemistry. 51(21). 6631–6634. 63 indexed citations
5.
Elkins, P.A., Joseph Watts, Magdalena Zalacaín, et al.. (2003). Insights into Catalysis by a Knotted TrmD tRNA Methyltransferase. Journal of Molecular Biology. 333(5). 931–949. 107 indexed citations
6.
Seefeld, Mark A., William H. Miller, Kenneth A. Newlander, et al.. (2003). Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK. Journal of Medicinal Chemistry. 46(9). 1627–1635. 133 indexed citations
7.
Elkins, P.A., Ward W. Smith, Cheryl A. Janson, et al.. (2002). Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase. Acta Crystallographica Section D Biological Crystallography. 58(7). 1182–1192. 124 indexed citations
8.
Elkins, P.A., Amy Bunker, William Cramer, & Cynthia V. Stauffacher. (1997). A mechanism for toxin insertion into membranes is suggested by the crystal structure of the channel-forming domain of colicin E1. Structure. 5(3). 443–458. 117 indexed citations
9.
Cramer, William A., et al.. (1995). Structure-Function of the Channel-Forming Colicins. Annual Review of Biophysics and Biomolecular Structure. 24(1). 611–641. 169 indexed citations
10.
Elkins, P.A., Ho Yeong Song, William Cramer, & Cynthia V. Stauffacher. (1994). Crystallization and characterization of colicin E1 channel‐forming polypeptides. Proteins Structure Function and Bioinformatics. 19(2). 150–157. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026